This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Computed Tomography  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

Paolo Raggi, MD

Arch Intern Med. 2006;166:1068-1071.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Though coronary artery disease (CAD) remains the first cause of morbidity and mortality in the United States (http://www.americanheart.org), screening for asymptomatic disease has been at the center of a vivid debate for a long time. Several councils and professional associations have endorsed screening for subclinical atherosclerosis in selected patients. The American Heart Association/American College of Cardiology¹ and experts of the National Cholesterol Education Program III (NCEP-III)² suggested that screening may provide incrementally useful information in subjects judged to be at intermediate risk by traditional risk factors. The European Society of Cardiology³ recently noted that CAC is a sensitive marker of atherosclerosis, and it should not be used as a marker for underlying coronary luminal stenosis. Rather it should be used as a tool to improve risk assessment in individual patients. This organization further acknowledged that the prognostic relevance of CAC has been demonstrated in several . . . [Full Text of this Article]

AUTHOR INFORMATION

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Repeatability Limits for Measurement of Coronary Artery Calcified Plaque with Cardiac CT in the Multi-Ethnic Study of Atherosclerosis
Chung et al.
Am. J. Roentgenol. 2008;190:W87-W92.
ABSTRACT | FULL TEXT